Volume 70
2009
Supplement 2

Insights Into Generalized Anxiety Disorder

CME Background Information

[PDF]

ARTICLES

4 Overview of Generalized Anxiety Disorder: Epidemiology, Presentation, and Course

[PDF] [Abstract]

10 Generalized Anxiety Disorder and Psychiatric Comorbidities Such as Depression, Bipolar Disorder, and Substance Abuse

[PDF] [Abstract]

15 Neurobiology of Generalized Anxiety Disorder

[PDF] [Abstract]

20 Generalized Anxiety Disorder and Medical Illness

[PDF] [Abstract]

25 First-Line Pharmacotherapy Approaches for Generalized Anxiety Disorder

[PDF] [Abstract]

32 Refractory Generalized Anxiety Disorder

[PDF] [Abstract]

CME Section

39 Posttest and Evaluation.

[PDF]

Editor’s Choice

For those of us in primary care, generalized anxiety disorder (GAD) is a condition that adds greatly to our workload while worsening the health of our patients. GAD, which often develops early in life, may play a role in the development of other psychiatric illnesses as well as a number of chronic medical illnesses. Intriguingly, adequate early treatment of GAD may be preventive. The articles in this supplement provide the information necessary to recognize GAD and to understand its wideranging effects on other psychiatric conditions and chronic medical conditions, the importance and benefits of treating it, the need of most patients for long-term treatment, and the options and best strategies for individualizing treatment for our patients. This supplement provides the information necessary for “state-of-the-evidence” care. I invite you to take advantage of this educational opportunity!

Larry Culpepper, MD, MPH

Editor in Chief

The Primary Care Companion to the Journal of Clinical Psychiatry